InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Plans Presentation at Unique Access to Giving Virtual Investor Conference
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and quality of life for patients who have unmet medical needs, is slated to present at the upcoming Access to Giving virtual conference. The conference is scheduled for July 14, 2021; PCSA’s presentation will begin at 10:30 a.m. ET. PCSA CEO Dr. David Young will make the presentation during the conference,…